However, the variability of onset and dynamics of Wilms tumor development in these Wt1-Igf2 mice dictates the need for highly sensitive non-invasive imaging, to enable early detection of tumor lesions in kidneys and for longitudinal monitoring of their progression or regression for the assessment of novel therapeutic strategies targeting IGF and ERK signaling pathways. The gene discussed is WT1; the disease is Wilms tumor.